Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease

NCT04220450 is registered in ClinicalTrials.gov with Dr. Andreas Kammerlander as lead sponsor.

NCT NCT04220450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease
Lead sponsor
Dr. Andreas Kammerlander
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 15, 2021
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease, heart failure, nafld, valvular disease